glp-1 instructions 🚨 Big news for people with type 1 diabetes who are using or are interested in using a GLP-1! 35 new recommendations have been published for use of GLP-1s and GLP-1/GIP in The GLP-1 Trap: Your Jumpstart

Melanotan I and Melanotan II have both been tested in small clinical trials

The specific thresholds that should prompt dose reduction or discontinuation include: ALT or AST elevation exceeding 3 times the patient's baseline value, new or worsening coagulopathy (INR increase of 0.5 or more from baseline), albumin decline below 2.5 g/dL, or new clinical signs of hepatic decompensation such as worsening ascites, encephalopathy, or jaundice [5]

doi: 10.4183/aeb.2022.216

Choosing a licensed provider significantly reduces these risks

Medical community engagement through professional societies supports standardization of treatment protocols and prescribing practices